Pyelonephritis treatment in the community emergency department: Cephalosporins vs. first-line agents - 15/10/18
, Emily Pavich Abstract |
Objective |
The purpose of this study was to assess treatment with a fluoroquinolone or trimethoprim-sulfamethoxazole versus cephalosporins for pyelonephritis in discharged patients from a community hospital setting.
Methods |
A retrospective chart review was completed for adult female patients who received a prescription for a cephalosporin, fluoroquinolone or trimethoprim-sulfamethoxazole for the treatment of pyelonephritis within the network of a large healthcare system. The primary endpoint evaluated the failure rate of each treatment group. The secondary endpoint evaluated the difference between rates of resistance on culture and sensitivity reports for treatment groups.
Results |
A total of 55 patients in the cephalosporin group and 43 patients in the fluoroquinolone and trimethoprim-sulfamethoxazole group were reviewed. The primary endpoint occurred in 0% of the patients in the cephalosporin group and in 23% of the patients in the fluoroquinolone and trimethoprim-sulfamethoxazole group, p < 0.001. Of the 98 urine samples collected, 71 samples were positive for pathogen growth. Upon evaluation of these isolates, 6% were resistant to cephalexin, 1% was resistant to cefdinir, 3% were resistant to ciprofloxacin and 23% were resistant to trimethoprim-sulfamethoxazole. Trimethoprim-sulfamethoxazole showed statistical significance for more bacterial resistance compared to the other agents, p < 0.01.
Conclusion |
Failure of therapy for pyelonephritis occurred more often in the fluoroquinolone and trimethoprim-sulfamethoxazole group than in the cephalosporin group. The findings in this study are most applicable to patients who are treated on an outpatient basis. A prospective, randomized clinical trial is necessary to confirm these results.
Le texte complet de cet article est disponible en PDF.Abbreviations : ED, IDSA, ICD-10-CM
Keywords : Pyelonephritis, Oral antibiotics, Fluoroquinolones, Trimethoprim-sulfamethoxazole, Cephalosporins, Emergency Department
Plan
| ☆ | This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Work previously presented as a poster at the ASHP Midyear Conference and as a brief lecture at the Great Lakes Pharmacy Resident Conference. |
Vol 36 - N° 11
P. 2054-2057 - novembre 2018 Retour au numéro
Article précédent
- Reducing mortality in near-hanging patients with a novel early management protocol
- Muralitharan Tharmarajah, Hamza Ijaz, Mimi Vallabhai, Narendra Nath Jena, Maxine LeSaux, Jeffrey P. Smith, Chen Chen, Yan Ma, Katherine A. Douglass, Andrew C. Meltzer
- Urgent care peripheral nerve blocks for refractory trigeminal neuralgia
- Michael D. Perloff, Justin S. Chung
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?